Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Research To Practice | Oncology Videos
00:00
HER2 Targeting in Metastatic Colon Cancer
John discusses HER2 prevalence, tucatinib+trastuzumab and T‑DXd data, dosing, toxicity, and sequencing strategies.
Play episode from 46:51
Transcript
